A Plus Biotechnology Co., Ltd.
A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides technical support services and labor services. A Plus Biotechnology Co., Ltd. is based in New Taipei City, Ta… Read more
Market Cap & Net Worth: A Plus Biotechnology Co., Ltd. (6918)
A Plus Biotechnology Co., Ltd. (TW:6918) has a market capitalization of $89.23 Million (NT$2.95 Billion) as of March 19, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #20316 globally and #1054 in its home market, demonstrating a 1.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying A Plus Biotechnology Co., Ltd.'s stock price NT$85.40 by its total outstanding shares 34571000 (34.57 Million).
A Plus Biotechnology Co., Ltd. Market Cap History: 2025 to 2026
A Plus Biotechnology Co., Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $89.34 Million to $89.23 Million (0.00% CAGR).
A Plus Biotechnology Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how A Plus Biotechnology Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6918 by Market Capitalization
Companies near A Plus Biotechnology Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to A Plus Biotechnology Co., Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
A Plus Biotechnology Co., Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, A Plus Biotechnology Co., Ltd.'s market cap moved from $89.34 Million to $ 89.23 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$89.23 Million | -0.12% |
| 2025 | NT$89.34 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of A Plus Biotechnology Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $89.23 Million USD |
| MoneyControl | $89.23 Million USD |
| MarketWatch | $89.23 Million USD |
| marketcap.company | $89.23 Million USD |
| Reuters | $89.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.